Clinical Study

Quinolone Prophylaxis in Transrectal Ultrasound Guided Prostate Biopsy: An Eight-Year Single Center Experience

Figure 1

Febrile UTI rate per year of assessment. (a) FQ-S rate: fluoroquinolone-sensitive febrile UTI rate. (b) FQ-R rate: fluoroquinolone-resistant febrile UTI rate. The infection (febrile UTI) rates (%) were 3.6, 3.9, 3.5, 1.5, 0.7, 0.6, 1.2, and 1.2 in 2002, 2003, 2004, 2005, 2006, 2007, 2008, and 2009, respectively. The FQ-S rates (%) were 3.6, 3.4, 3.1, 0.6, 0.2, 0.4, 0.2, and 0.6 in 2002, 2003, 2004, 2005, 2006, 2007, 2008, and 2009, respectively. The FQ-R rates (%) were 0, 0.5, 0.3, 0.8, 0.5, 0.2, 1.0, and 0.6 in 2002, 2003, 2004, 2005, 2006, 2007, 2008, and 2009, respectively.
452107.fig.001